TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.030 (1.45%)
Apr 28, 2026, 4:00 PM EDT - Market closed
TherapeuticsMD Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 7.48 | 5.06 | 4.33 | 38.07 | 64.91 | Upgrade
|
| Cash & Short-Term Investments | 7.48 | 5.06 | 4.33 | 38.07 | 64.91 | Upgrade
|
| Cash Growth | 47.91% | 16.92% | -88.63% | -41.35% | -19.36% | Upgrade
|
| Accounts Receivable | 3.53 | 3.56 | 3.09 | - | - | Upgrade
|
| Other Receivables | 0.67 | 0.54 | - | - | - | Upgrade
|
| Receivables | 4.2 | 4.1 | 3.09 | - | - | Upgrade
|
| Prepaid Expenses | 0.09 | 0.07 | 0.25 | 1.17 | 2.73 | Upgrade
|
| Restricted Cash | - | - | - | 11.25 | - | Upgrade
|
| Other Current Assets | 2.68 | 3.03 | 4.13 | 4.87 | 51.83 | Upgrade
|
| Total Current Assets | 14.45 | 12.26 | 11.8 | 55.35 | 119.47 | Upgrade
|
| Property, Plant & Equipment | 5.29 | 6.1 | 6.87 | 7.66 | 9.06 | Upgrade
|
| Other Intangible Assets | 3.76 | 4.32 | 6.1 | 6.94 | 7.14 | Upgrade
|
| Long-Term Accounts Receivable | 13.71 | 16.01 | 18.48 | 20.25 | - | Upgrade
|
| Other Long-Term Assets | 0.44 | 0.13 | 0.06 | 0.25 | 33.8 | Upgrade
|
| Total Assets | 37.66 | 38.82 | 43.31 | 90.46 | 169.47 | Upgrade
|
| Accounts Payable | 0.38 | 0.26 | 0.03 | 2.16 | 3.37 | Upgrade
|
| Accrued Expenses | 0.77 | 0.49 | 1.66 | 12.76 | 9.12 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 188.27 | Upgrade
|
| Current Portion of Leases | 0.98 | 1.63 | 1.47 | 1.39 | 1.36 | Upgrade
|
| Other Current Liabilities | 2.67 | 2.78 | 3.69 | 30.53 | 50.77 | Upgrade
|
| Total Current Liabilities | 4.79 | 5.17 | 6.85 | 46.84 | 252.89 | Upgrade
|
| Long-Term Leases | 5.12 | 5.54 | 6.53 | 7.37 | 8.06 | Upgrade
|
| Other Long-Term Liabilities | 0.87 | 0.74 | 0.64 | 1.11 | 2.14 | Upgrade
|
| Total Liabilities | 10.78 | 11.45 | 14.02 | 55.32 | 263.09 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 979.26 | 979.18 | 978.92 | 974.5 | 957.73 | Upgrade
|
| Retained Earnings | -952.39 | -951.82 | -949.64 | -939.36 | -1,051 | Upgrade
|
| Shareholders' Equity | 26.88 | 27.37 | 29.29 | 35.14 | -93.62 | Upgrade
|
| Total Liabilities & Equity | 37.66 | 38.82 | 43.31 | 90.46 | 169.47 | Upgrade
|
| Total Debt | 6.1 | 7.18 | 8.01 | 8.76 | 197.69 | Upgrade
|
| Net Cash (Debt) | 1.39 | -2.12 | -3.68 | 29.31 | -132.79 | Upgrade
|
| Net Cash Per Share | 0.12 | -0.18 | -0.35 | 3.13 | -16.68 | Upgrade
|
| Filing Date Shares Outstanding | 11.57 | 11.57 | 11.53 | 9.95 | 8.67 | Upgrade
|
| Total Common Shares Outstanding | 11.57 | 11.53 | 11.53 | 9.5 | 8.6 | Upgrade
|
| Working Capital | 9.66 | 7.09 | 4.94 | 8.51 | -133.42 | Upgrade
|
| Book Value Per Share | 2.32 | 2.37 | 2.54 | 3.70 | -10.89 | Upgrade
|
| Tangible Book Value | 23.12 | 23.05 | 23.19 | 28.2 | -100.77 | Upgrade
|
| Tangible Book Value Per Share | 2.00 | 2.00 | 2.01 | 2.97 | -11.72 | Upgrade
|
| Machinery | - | - | - | 2.1 | 2.34 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.05 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.